Breaking News

ICON, Empire Genomics in Personalized Medicine Pact

Combined service offering aims to streamline drug development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON and Empire Genomics have entered a strategic alliance to develop a service portfolio for the development of personalized medicines. The partnership combines Empire Genomics’ expertise in pharmacogenomics, computational modeling of disease state, drug disposition and drug targets with ICON’s translational medicine, clinical trial design and biomarkers expertise. The combined service offering aims to enable the identification of responder target populations, permit the stratification of patie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters